Skip to main content
Premium Trial:

Request an Annual Quote

Aurora Hires Former GeneProt Exec as VP, Business Development

NEW YORK, March 23 – Aurora Biosciences said it has hired William Ettouati, former co-CEO of Geneva Proteomics, as vice president of business development.

Ettouati, who was at the helm of Geneva Proteomics from April to August of last year, will seek to expand Aurora’s business in Europe and develop other strategic alliances, Aurora said. Before his term at GeneProt, Ettouati headed up Ceptyr, a Seattle-based biotech company developing PTP-based therapeutics. 

San Diego-based Aurora has also promoted three executives within its ranks. Christopher Krueger, formerly vice president of strategic alliances and legal affairs, will be Aurora’s general counsel and vice president, strategic alliances; Pamela Fritz has been promoted from senior director, Human Resources to vice president, Human Resources; and Brian Pollok, has been has been promoted from director, Discovery Biology to vice president, Discovery Biology.

Pollok will head up efforts to integrate the scientific and business aspects of Panvera, a Madison, Wisc. -based manufacturer of recombinant protein drug targets and protein drug screening assays, Aurora said.

Aurora Biosciences of San Diego develops and applies proprietary technologies designed to accelerate the discovery of new medicines.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.